Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bone metastatic variant of MCF7 cells

ABSTRACT: Bone metastatic variant of MCF7 cells

PROVIDER: PRJNA498077 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8097390.fastq.gz	Fastqsanger.gz
	SRR8097400.fastq.gz	Fastqsanger.gz
	SRR8097391.fastq.gz	Fastqsanger.gz
	SRR8097401.fastq.gz	Fastqsanger.gz
	SRR8097392.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Bone metastatic variant of MCF7 cells

Project description:A bone-metastatic variant of MCF7 cells was created from a spontaneous metastasis from the mammary fat pad to the bone marrow in the absence of exogenous estrogen. The goal of the study was to determine differences in gene expression between the parental MCF7 cells and the bone metastatic variant.

2021-09-15 | GSE121677 | GEO

Identification of genes associated with bone metastatic breast cancer cells

Project description:We used comparative RNA hybridization (Affymetrix) analysis between Bone metastatic derivatives isolated in vivo and parental cells and focused on changes affecting the expression of potential bone metastasis genes. Total RNA from biological and technical replicates of parental MCF7 and BoM2 bone metastasis derivatives grown for 48 hours in regular media (see growth protocol) was isolated from in vitro cultured control and MAF expressing MCF7 parental cells. Total RNA was extracted using the TRIzolM-BM-. Plus RNA Purification Kit (Life Technologies).

2014-10-01 | E-GEOD-51232 | biostudies-arrayexpress

Identification of CNA associated with bone metastatic breast cancer cells

Project description:We used comparative genomic hybridization (CGH) analysis between Bone metastatic derivatives isolated in vivo and parental cells and focused on genomic changes affecting the expression of potential bone metastasis. Total RNA from biological and technical replicates of parental MCF7 and BoM2 bone metastasis derivatives grown for 48 hours in regular media (see growth protocol). High-molecular DNA was isolated from in vitro cultured MCF7 and BoM2 cells using GeneEluteM-bM-^DM-" Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich) following manufactureM-bM-^@M-^Ys instructions.

2014-10-01 | E-GEOD-51237 | biostudies-arrayexpress

Expression data of extracellular vesicles from bone metastatic breast cancer cell line

Project description:Bone metastasis is an incurable complication of breast cancer. In advanced stages, patients with estrogen-positive tumors experience significantly higher incidence of bone metastasis compared to estrogen-negative patients. To investigate how estrogen-positive breast cancer cells communicate with bone microenvironmental cells, extracellular vesicles from bone metastatic MCF7BoM2 were purified and analyzed. We used GeneChip miRNA 4.1 Array to detail the miRNA expression in the extracellular vesicles from the bone metastatic MCF7BoM2 and its parental cell line MCF7, and identified the dysregulated miRNAs.

2021-06-04 | GSE176105 | GEO

Bone invigorates metastatic seeding

Project description:Bone invigorates metastatic seeding

| PRJNA675666 | ENA

Exon level expression profile of MCF7 cells with p53β splice variant knocked out 4hr post 20gy irradiation

Project description:In order to explore the funciton of p53β splice variant in DNA damage response, we utilized CRISPR-cas9 genome editing technique to specifically knock out this variant in MCF7 cells. Microarray analysis is then performed to compare gene expression before and after 20gy irradiation in these cells.

2017-08-31 | GSE84813 | GEO

Comparing gene-expression profiles between bone-metastatic vs. non bone-metastatic human prostate cancer cells

Project description:Disseminated prostate cancer cells colonize the skeleton to progress into macroscopic lesions only if they successfully adapt to the bone microenvironment. We previously reported that the ability of prostate cancer cells to generate skeletal tumors in animal models correlated with the expression of the alpha-receptor for Platelet-Derived Growth Factor (PDGFRa). In this study we aimed to identify PDGFRa-regulated genes responsible for the acquisition of a bone-metastatic prostate phenotype. We performed genome-wide expression comparative analyses of human prostate cancer cell lines that differ for PDGFRa expression and propensity to establish tumors in the skeleton of animal models. We investigated the genes that were differentially regulated in the highly bone-metastatic PC3-ML cells and their low-metastatic counterpart PC3-N cells, and the genes differentially regulated between PC3-N and PC3-N with overexpression of PDGFRa (PC3NRa). We have previously shown that DU-145 cells lack PDGFRa and fail to survive longer than three days as disseminated tumor cells after homing to the mouse bone marrow. Interestingly, and in contrast to PC3-N cells, the exogenous expression of PDGFRa did not promote metastatic bone-tropism of DU-145 cells in our model. Thus, we examined the genes that were differentially regulated between DU-145 and DU-145(Ra) and excluded them from our candidate genes. Finally, to refine our findings and compensate for PC3 and DU-145 genetic disparity, we performed a comparative analysis of the genes differentially regulated between two bone metastatic single-cell progenies that were derived from PC3-ML cells. Seven human prostate cancer cell lines were analyzed in total for this study. Each cell line was analyzed in duplicate from two different passages in culture.

2013-03-30 | E-GEOD-43332 | biostudies-arrayexpress

Comparing gene-expression profiles between bone-metastatic vs. non bone-metastatic human prostate cancer cells

2013-03-30 | GSE43332 | GEO

Comparison between MCF7-IKKe overexpressing cells and MCF7 control cells

Project description:Comparison between MCF7-IKKe overexpressing cells and MCF7 control cells

| PRJNA451476 | ENA

Identification of CNA associated with bone metastatic breast cancer cells

2014-10-01 | GSE51237 | GEO